Renal Infarction: Diagnostic Evaluation and Acute Treatment
Immediate Diagnostic Approach
Contrast-enhanced CT scan is the essential diagnostic test for renal infarction and should be obtained urgently in patients with acute flank or abdominal pain when this diagnosis is suspected. 1, 2
Clinical Presentation to Recognize
- Flank or abdominal pain is present in 90-100% of cases, often severe and persistent 3, 4
- Classic diagnostic triad (present in 80% of cases): persistent flank/abdominal pain with tenderness, elevated serum LDH (mean >800 U/L in 95% of patients), and proteinuria 4
- Risk factors are present in 90% of patients and include: 3, 5, 4
- Atrial fibrillation (28-55% of cases)
- Valvular or ischemic heart disease
- Hypertension (44%)
- Prior thromboembolic events
- Hypercoagulable states
- Obesity, smoking, diabetes
- Idiopathic cases account for 30% despite thorough workup 1, 5
Diagnostic Testing Algorithm
Primary imaging:
- Contrast-enhanced CT abdomen/pelvis is the gold standard, showing wedge-shaped perfusion defects in renal parenchyma 1, 5, 2
- This should be obtained immediately when renal infarction is suspected, as diagnosis is frequently delayed or missed at initial presentation 4
Laboratory evaluation:
- Serum LDH (elevated in 95% of cases) 4
- Serum creatinine (mean 1.2 mg/dL at presentation, but acute kidney injury occurs in 20% during hospitalization) 3, 5
- Urinalysis (proteinuria common; negative for infection helps exclude pyelonephritis) 1, 4
- Complete thrombophilia workup if no obvious cardioembolic source 5, 2
Cardiac evaluation:
- ECG and echocardiography to identify cardioembolic sources (atrial fibrillation, valvular disease) 5, 2
Acute Treatment Protocol
Anticoagulation with low molecular weight heparin is the cornerstone of acute management and should be initiated immediately upon diagnosis. 3, 5
Medical Management
Anticoagulation therapy:
- Low molecular weight heparin (used in 83% of cases) is the preferred initial treatment 3
- Transition to warfarin for long-term anticoagulation (used in 75% of cases) 5
- Aspirin alone (11%) is insufficient for most cases 3
Thrombolytic therapy:
- Urokinase (peripheral IV or local intra-arterial) was used in 25% of cases in one series 5, 4
- Consider for patients with bilateral infarction, solitary kidney involvement, or rapidly declining renal function 5
- No clear guideline consensus exists on thrombolytic indications, but should be considered in high-risk scenarios 2
Prognosis and Outcomes
Despite aggressive treatment, significant complications occur:
- Acute kidney injury develops in 20% during initial hospitalization 5
- New-onset eGFR <60 mL/min/1.73 m² occurs in 11% of patients 5
- End-stage renal disease requiring dialysis develops in 2% 5
- In-hospital mortality is 5% 5
- Recurrence rate is 2.8% during median 20-month follow-up 5
- Reduced differential kidney function on DMSA scintigraphy occurs in 58% at 8-month follow-up 3
Critical Pitfalls to Avoid
- Do not dismiss the diagnosis in patients with unexplained flank pain and risk factors for thromboembolism, even if initial presentation mimics more common conditions like pyelonephritis or nephrolithiasis 1, 2
- Do not delay contrast-enhanced CT when renal infarction is suspected—the diagnosis is missed or delayed in 50% of cases at initial ED presentation 4
- Do not withhold anticoagulation while awaiting definitive diagnosis if clinical suspicion is high and no contraindications exist 3, 5
- Do not assume normal creatinine excludes significant infarction—mean creatinine at presentation is only mildly elevated (1.2 mg/dL), but long-term renal dysfunction can develop 3, 5